Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beautifil Flow Plus X
- Development stage
- Unknown
- Lead developer
- SHOFU Dental
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
Beautifil Flow Plus X is a bioactive injectable hybrid composite resin developed by Shofu Dental Corporation for use in dental restorations. It incorporates proprietary Giomer technology, which features Surface Pre-Reacted Glass (S-PRG) fillers that enable the material to release and recharge six beneficial ions: fluoride, strontium, borate, aluminum, silicate, and sodium. These ions contribute to anti-plaque effects and the neutralization of acids, helping to prevent secondary caries. The material is indicated for Class I through V restorations and is available in two viscosities (F00 for zero flow and F03 for low flow), offering high compressive strength, wear resistance, and excellent polishability. It is frequently used in pediatric dentistry for the restoration of primary teeth due to its ease of application and bioactive properties.
- Brand names
- Beautifil Flow Plus X
- Other names
- injectable composite resin restorationBeautifil Flow Plus X F00Beautifil Flow Plus X F03
Beyond the preview
Go deeper on Beautifil Flow Plus X.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beautifil Flow Plus X.